{"mcpName":"station__algovigilance__microgram-fda-clinical-hold-criteria","slug":"algovigilance__microgram-fda-clinical-hold-criteria","label":"Microgram: fda-clinical-hold-criteria","description":"FDA clinical hold decision criteria: routes by hold basis and study phase per 21 CFR 312.42","domainSlug":"algovigilance","pvRelevance":"pv-core","backend":"native","agentMetadata":{"idempotent":true,"read_only":true,"expected_latency_ms":null,"cost_tokens_estimate":null,"pipes_to":null},"inputSchema":{"type":"object","properties":{"hold_basis":{"type":"string","description":"Basis for clinical hold: unreasonable_risk, unqualified_investigators, misleading_brochure, insufficient_toxicology, deficient_protocol, deficient_informed_consent"},"study_phase":{"type":"string","description":"Clinical trial phase: phase1, phase2, phase3, phase4, babe"},"prior_hold":{"type":"boolean","description":"Whether the IND has been on hold previously for the same issue"}},"required":["hold_basis"],"additionalProperties":false},"example":null,"taxonomy":{"rank":{"domain":"Substrata","kingdom":"Constructa","phylum":"Configa","class":"station-config","order":"algovigilance","family":"mcp-tool-config"},"characteristics":{"substrate":"config","domain":"pv","lifecycle":"continuous","stateful":false,"persistence":"none","authority":"read","compounding":"producer","io_input":"agent-request","io_output":"tool-response"}},"_links":{"html":"/tools/algovigilance__microgram-fda-clinical-hold-criteria","markdown":"/tools/algovigilance__microgram-fda-clinical-hold-criteria/raw.md","invoke":"/api/mcp","catalog":"/api/mcp"}}